Two week induction of interferon-beta followed by pegylated interferon alpha-2b and ribavirin for chronic infection with hepatitis C
Author:
Publisher
Wiley
Subject
Infectious Diseases,Hepatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1872-034X.2010.00669.x/fullpdf
Reference17 articles.
1. Natural history of hepatitis-related hepatocellular carcinoma;But;World J Gastroenterol,2008
2. Telaprevir and peginterferon with or without ribavirin for chronic HCV infection;Hezode;N Engl J Med,2009
3. Efficacy of the combination therapy using twice-a-day IFN-beta followed by IFN alpha-2b in treatment for chronic hepatitis C;Okushin;Kanzo,1997
4. Potent induction therapy with interferon and ribavirin combination therapy does not achieve a higher sustained virological response rate in chronic hepatitis C with genotype 1b and high hepatitis C virus RNA level;Enomoto;Hepatol Res,2007
5. Differences between interferon-alpha and -beta treatment for patients with chronic hepatitis C virus infection;Furusyo;Dig Dis Sci,1999
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Retreatment with sofosbuvir/ledipasvir with or without lead-in interferon-β injections in patients infected with genotype 1b hepatitis C virus after unsuccessful daclatasvir/asunaprevir therapy;Hepatology Research;2017-10-20
2. Human Ebola virus infection in West Africa: a review of available therapeutic agents that target different steps of the life cycle of Ebola virus;Infectious Diseases of Poverty;2014-11-28
3. Hepatitis C virus core antigen testing: Role in diagnosis, disease monitoring and treatment;World Journal of Gastroenterology;2014
4. Long-term Evaluation of Partial Splenic Embolization Followed by Interferon Therapy in Patients with Hepatitis C Virus (HCV) Cirrhosis and Thrombocytopenia;Internal Medicine;2014
5. Lead-in treatment with interferon-β/ribavirin may modify the early hepatitis C virus dynamics in pegylated interferon alpha-2b/ribavirin combination for chronic hepatitis C patients with the IL28B minor genotype;Journal of Gastroenterology and Hepatology;2013-02-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3